.jpg)
Latest News
Four states are reporting recent progress on preventing pseudoephedrine diversion after implementing a real-time, stop-sale tracking system.
Even short-term treatment with nonsteroidal anti-inflammatory drugs is associated with significant increases in bleeding and cardiovascular event risk in patients receiving antithrombotic therapy after a heart attack.
Although believed to be distinct, different psychiatric disorders may produce similar loss of gray matter in the brain.
Americans are fortunate to have abundant food sources, but the flip side is the country’s obesity epidemic.
A patient’s hospital readmission likelihood relies more heavily on community factors than care at discharge, according to a study published in Health Services Research.
Is it possible for Twitter to predict a community's level of heart disease?
Sanofi has announced the FDA approval of its insulin glargine injection (Toujeo), a once-daily long-acting basal insulin, for the improvement of glycemic control in adults with type 1 and type 2 diabetes.
Five pharmacy schools received kudos from the CEO of the American Pharmacists Association for earning the highest rates of participation in the Pharmacists Provide Care Campaign.
The FDA today approved ceftazidime-avibactam, an antibacterial drug for patients with complicated intra-abdominal infections, in combination with metronidazole, and complicated urinary tract infections.
Trending Now
Pharmacist Education
Educated Patient
If you suffer from migraines, you are not alone.
Various treatments for osteoarthritis can decrease pain and maintain joint mobility.
With proper treatment, individuals with atrial fibrillation can live normal and active lives.
Sore throats lasting longer than a week require medical attention.
Strategic Alliance Partners
Latest Issues
